InterCure to Participate in Cowen’s 4th Annual Cannabis Conference

Rhea-AI Summary

InterCure Ltd (NASDAQ: INCR) announces participation in Cowen’s 4th Annual Cannabis Conference from November 29 - December 1, 2021. CEO Alexander Rabinovitch will join the ‘International’ panel on November 30 at 11:50 a.m. ET. The event is virtual, allowing management to hold one-on-one meetings with institutional and corporate clients. InterCure, operating as Canndoc, is Israel's largest licensed cannabis producer and a leader in the rapidly growing cannabis market outside North America.

Mr. Rabinovitch to participate in the ‘International’ panel at 11:50 a.m. ET on Tuesday, November 30, 2021

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 29, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen’s 4^th Annual Cannabis Conference, taking place virtually from November 29 - December 1, 2021.

Mr. Rabinovitch will participate in the ‘International’ panel at 11:50 a.m. ET on Tuesday, November 30, 2021.

Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. To find out more, please visit the conference website at https://www.cowen.com/conferences-and-events/4th-annual-cannabis-conference/.

If you are interested in scheduling a one-on-one meeting with InterCure’s management team, please contact InterCure@kcsa.com.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@canndoc-pharma.com

KCSA Strategic Communications
Investor and Media Relations
InterCure@kcsa.com

 

FAQ

What is InterCure's role in the 4th Annual Cannabis Conference?

InterCure's CEO, Alexander Rabinovitch, will participate in the ‘International’ panel on November 30, 2021.

When is the Cowen Cannabis Conference taking place?

The Cowen Cannabis Conference is scheduled from November 29 to December 1, 2021.

What is the significance of InterCure in the cannabis industry?

InterCure is the largest licensed cannabis producer in Israel and is known for its high-margin, vertically integrated model.

How can I schedule a meeting with InterCure's management?

Interested parties can contact InterCure at InterCure@kcsa.com to schedule one-on-one meetings.

What products does Canndoc offer?

Canndoc offers GMP certified and pharmaceutical-grade medical cannabis products.